Education
About Us
Working with TipRanks
Follow Us
PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
Total Valuation
PDS Biotechnology has a market cap or net worth of $49.03M. The enterprise value is $41.75M.
Market Cap$49.03M
Enterprise Value$41.75M
Share Statistics
PDS Biotechnology has 45.40M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45.40M
Owned by Insiders1.34%
Owned by Instutions0.74%
Financial Efficiency
PDS Biotechnology’s return on equity (ROE) is -2.07 and return on invested capital (ROIC) is -90.96%.
Return on Equity (ROE)-207.05%
Return on Assets (ROA)-86.75%
Return on Invested Capital (ROIC)-90.96%
Return on Capital Employed (ROCE)-128.47%
Revenue Per Employee$0
Profits Per Employee-$1,689,843.667
Employee Count24
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PDS Biotechnology is >-0.01. PDS Biotechnology’s PEG ratio is >-0.01.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio>-0.01
Income Statement
In the last 12 months, PDS Biotechnology had revenue of $0.00 and earned -$40.56M in profits. Earnings per share was -$1.16.
Revenue$0.00
Gross Profit-$43.94K
Operating Income-$39.37M
Pretax Income-$41.43M
Net Income-$40.56M
EBITDA-36.61M
Earnings Per Share (EPS)-1.16
Cash Flow
In the last 12 months, operating cash flow was -$35.25M and capital expenditures -$29.00K, giving a free cash flow of -$35.28M billion.
Operating Cash Flow-$35.25M
Free Cash Flow-$35.28M
Free Cash Flow per Share-$0.78
Dividends & Yields
PDS Biotechnology pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-58955.66%
Earnings Yield-66223.67%
Stock Price Statistics
Beta2.45
52-Week Price Change-60.36%
50-Day Moving Average1.28
200-Day Moving Average2.41
Relative Strength Index (RSI)46.52
Average Volume (3m)643.58K
Important Dates
PDS Biotechnology upcoming earnings date is May 14, 2025, Before Open.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
PDS Biotechnology as a current ratio of 2.64, with Debt / Equity ratio of 0.66
Current Ratio2.64
Quick Ratio2.64
Debt to Market Cap212.44
Net Debt to EBITDA0.80
Interest Coverage Ratio7.77
Taxes
In the past 12 months, PDS Biotechnology has paid -$869.16K in taxes.
Income Tax-$869.16K
Effective Tax Rate-2.26%
Enterprise Valuation
PDS Biotechnology EV to EBITDA ratio is 0.80, with an EV/FCF ratio of 0.83.
EV to Sales0.00
EV to EBITDA0.80
EV to Free Cash Flow0.83
EV to Operating Cash Flow0.83
Balance Sheet
PDS Biotechnology has $49.75M in cash and marketable securities with $24.67M in debt, giving a net cash position of -$25.08M billion.
Cash & Marketable Securities$49.75M
Total Debt$24.67M
Net Cash-$25.08M
Net Cash Per Share-$0.55
Tangible Book Value Per Share$521.36
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PDS Biotechnology is $8.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.75
Price Target Upside710.19%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast25.51%